Viking Therapeutics, Inc.

VKTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$26.83-1.65%

2026-11-02

Financials

Valuation Metrics

Viking Therapeutics, Inc.'s Market Cap is $3.12B. At end of 2025 it was $4.01B. Ranked #1666 of 3,118 in US market (top 53%), #593 of 1,474 on NASDAQ (top 40%), #99 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 37%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$3.12B	US#1,666/3,118 Sec#99/265
Revenue	$0.00	US#2,858/3,118 Sec#193/265
Net Income	$-627M	US—/3,118 Sec—/265
Total Assets	$977M	US#2,742/3,118 Sec#159/265
Net Assets	$589M	US#2,349/3,118 Sec#130/265
Value
P/B	5.29x	US#2,513/3,118 Sec#182/265
FCF Yield	-14.85%	US—/3,118 Sec—/265
Profitability
ROE	-106.56%	US#2,806/3,118 Sec#210/265
ROA	-64.19%	US—/3,118 Sec—/265
Financial Health
Debt Ratio	66.02%	US#306/3,118 Sec#97/265
Total Debt	$255M	US#2,904/3,118 Sec#219/265
FCF	$-463M	US#2,878/3,118 Sec#247/265
Cash	$678M	US#2,055/3,118 Sec#149/265
Current Ratio	7.27x	US#499/3,118 Sec#150/265
Performance
1Y Return	-29.54%	US#2,569/3,118 Sec#204/265
1M Return	-10.39%	US#2,695/3,118 Sec#210/265
From 52W High	-37.82%	US#2,224/3,118 Sec#155/265
1Y MDD	-42.53%	US#2,047/3,118 Sec#132/265
Trading
Volume	4,389,876 shares	US#448/3,118 Sec#30/265
Trading Value	$119M	US#772/3,118 Sec#39/265
Per Share
EPS	$-5.40	US—/3,118 Sec—/265
BPS	$5.07	US#2,410/3,118 Sec#150/265